175 related articles for article (PubMed ID: 30984536)
1. Hypermethylation of the G protein-coupled receptor kinase 6 (GRK6) promoter inhibits binding of C/EBPα, and GRK6 knockdown promotes cell migration and invasion in lung adenocarcinoma cells.
Yao S; Wu D; Chen J; Wang P; Lv X; Huang J
FEBS Open Bio; 2019 Apr; 9(4):605-617. PubMed ID: 30984536
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of decreased GRK6 expression in lung adenocarcinoma.
Yao S; Zhong L; Liu J; Feng J; Bian T; Zhang Q; Chen J; Lv X; Chen J; Liu Y
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2541-2549. PubMed ID: 27601164
[TBL] [Abstract][Full Text] [Related]
3. Aberrant GRK6 promoter methylation is associated with poor prognosis in hypopharyngeal squamous cell carcinoma.
Qiu X; Chen J; Zhang Z; You Y; Wang Z
Oncol Rep; 2016 Feb; 35(2):1027-33. PubMed ID: 26718636
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the G protein-coupled receptor kinase 6 promoter reveals a functional CREB binding site.
Stegen M; Engler A; Ochsenfarth C; Manthey I; Peters J; Siffert W; Frey UH
PLoS One; 2021; 16(2):e0247087. PubMed ID: 33600497
[TBL] [Abstract][Full Text] [Related]
6. Growth factor receptor-Src-mediated suppression of GRK6 dysregulates CXCR4 signaling and promotes medulloblastoma migration.
Yuan L; Zhang H; Liu J; Rubin JB; Cho YJ; Shu HK; Schniederjan M; MacDonald TJ
Mol Cancer; 2013 Mar; 12():18. PubMed ID: 23497290
[TBL] [Abstract][Full Text] [Related]
7. Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma.
Kajiura K; Masuda K; Naruto T; Kohmoto T; Watabnabe M; Tsuboi M; Takizawa H; Kondo K; Tangoku A; Imoto I
Oncotarget; 2017 Jan; 8(2):2890-2905. PubMed ID: 27926516
[TBL] [Abstract][Full Text] [Related]
8. Genome-scale meta-analysis of DNA methylation during progression of lung adenocarcinoma.
Zhang QH; Dai XH; Dai ZM; Cai YN
Genet Mol Res; 2015 Aug; 14(3):9200-14. PubMed ID: 26345853
[TBL] [Abstract][Full Text] [Related]
9. Speckle-type POZ protein functions as a tumor suppressor in non-small cell lung cancer due to DNA methylation.
Yao S; Chen X; Chen J; Guan Y; Liu Y; Chen J; Lv X
Cancer Cell Int; 2018; 18():213. PubMed ID: 30607139
[TBL] [Abstract][Full Text] [Related]
10. C/EBPα Suppresses Lung Adenocarcinoma Cell Invasion and Migration by Inhibiting β-Catenin.
Lu J; Du C; Yao J; Wu B; Duan Y; Zhou L; Xu D; Zhou F; Gu L; Zhou H; Sun Y
Cell Physiol Biochem; 2017; 42(5):1779-1788. PubMed ID: 28746919
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of the expression of CCAAT/enhancer binding protein α gene in cervical squamous cell carcinoma.
Pan Z; Zheng W; Zhang J; Gao R; Li D; Guo X; Han H; Li F; Qu S; Shao R
BMC Cancer; 2014 Jun; 14():417. PubMed ID: 24913332
[TBL] [Abstract][Full Text] [Related]
12. GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt/β-catenin signaling in lung adenocarcinoma.
Yuan S; Yu Z; Liu Q; Zhang M; Xiang Y; Wu N; Wu L; Hu Z; Xu B; Cai T; Ma X; Zhang Y; Liao C; Wang L; Yang P; Bai L; Li Y
Oncogene; 2016 Nov; 35(47):6120-6131. PubMed ID: 27157618
[TBL] [Abstract][Full Text] [Related]
13. Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma.
Chen YC; Lin MC; Hsiao CC; Zheng YX; Chen KD; Sung MT; Chen CJ; Wang TY; Lin YY; Chang HC; Chen YM; Chang JC
Oncotarget; 2017 Jul; 8(28):45710-45724. PubMed ID: 28498804
[TBL] [Abstract][Full Text] [Related]
14. Aberrant DNA methylation of the transcription factor C/EBPalpha in acute myelogenous leukemia.
Jost E; do O N; Wilop S; Herman JG; Osieka R; Galm O
Leuk Res; 2009 Mar; 33(3):443-9. PubMed ID: 18757096
[TBL] [Abstract][Full Text] [Related]
15. Ribavirin-induced down-regulation of CCAAT/enhancer-binding protein α leads to suppression of lipogenesis.
Satoh S; Onomura D; Ueda Y; Dansako H; Honda M; Kaneko S; Kato N
Biochem J; 2019 Jan; 476(1):137-149. PubMed ID: 30552141
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of GAD1 overexpression in patients with resected lung adenocarcinoma.
Tsuboi M; Kondo K; Masuda K; Tange S; Kajiura K; Kohmoto T; Takizawa H; Imoto I; Tangoku A
Cancer Med; 2019 Aug; 8(9):4189-4199. PubMed ID: 31207151
[TBL] [Abstract][Full Text] [Related]
17. Roles of highly expressed PAICS in lung adenocarcinoma.
Zhou S; Yan Y; Chen X; Wang X; Zeng S; Qian L; Wei J; Yang X; Zhou Y; Gong Z; Xu Z
Gene; 2019 Apr; 692():1-8. PubMed ID: 30641222
[TBL] [Abstract][Full Text] [Related]
18. A possible gene silencing mechanism: hypermethylation of the Keap1 promoter abrogates binding of the transcription factor Sp1 in lung cancer cells.
Guo D; Wu B; Yan J; Li X; Sun H; Zhou D
Biochem Biophys Res Commun; 2012 Nov; 428(1):80-5. PubMed ID: 23047008
[TBL] [Abstract][Full Text] [Related]
19. miR‑30a‑3p suppresses the proliferation and migration of lung adenocarcinoma cells by downregulating CNPY2.
Wang H; Kanmangne D; Li R; Qian Z; Xia X; Wang X; Wang T
Oncol Rep; 2020 Feb; 43(2):646-654. PubMed ID: 31894275
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
